285. Global Elimination of Hepatitis C
Sunday, October 8, 2017: 8:00 AM-9:00 AM
Room: 01AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • compare methods of eradicating HCV infection
  • identify the key impediments for eradication
  • discuss the roles of prevention and treatment in eradication

Target Audience: Clinicians, Fellows, HIV clinicians, Infectious diseases pediatricians, Infectious diseases physicians, Pharmacists

Tracks: Pediatric ID, HIV-STD-TB, Global ID, Adult ID

Chair:  David Thomas, MD, MPH, FIDSA, Johns Hopkins University School of Medicine

Moderator:  John Ward, MD, Centers for Disease Control and Prevention/NCHHSTP

CME Credits: Maximum of 1.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-325-L01-P


D. Thomas, UpToDate: Editor , Salary
Oxford University Press: Editor , Salary
Merck: Scientific Advisor , Consulting fee

J. Ward, None

See more of: Mini-Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.